The position involves 80% research time and 20% teaching activities. The core tasks will include:
- contributing to the acquisition of external research funding for the benefit of the research programme;
- development and evaluation of pharmacoepidemiologic methods;
- contribution from the candidate to (maintaining) cooperation with (inter)national partners in the field of pharmacoepidemiology;
- coordinating and teaching pharmacoepidemiology related courses in the programmes of Pharmaceutical Sciences, Drug Innovation and the Pharmacoepidemiology Summer Programme;
- carrying out and (co-)supervising research (PhD and MSc) within the scope of the research programme.
The candidate is offered a full-time position for 1 year which can be extended after good evaluations. The gross salary is in the range between €3,111 and maximum €4,084 (scale 10 Collective Labour Agreement Dutch Universities) gross per month for a full-time employment.
The salary is supplemented with a holiday bonus of 8% and an end-of-year bonus of 8,3% per year. In addition we offer: a pension scheme, a partially paid parental leave, flexible employment conditions. Conditions are based on the Collective Labour Agreement Dutch Universities. The research group will provide the candidate with necessary support on all aspects of the project. More information is available at: working at Utrecht University.
Additional information about the vacancy can be obtained from: Prof. O.H. Klungel, PhD (
As part of the selection procedure, the candidate may be asked to give an outline of his/her research plans how to build a research line in pharmacoepidemiologic methods based on previous research experience and in alignment with the focus of UIPS and the Centre in a written report and/or an oral presentation.
A better future for everyone. This ambition motivates our scientists in executing their leading research and inspiring teaching. At Utrecht University, the various disciplines collaborate intensively towards major societal themes. Our focus is on Dynamics of Youth, Institutions for Open Societies, Life Sciences and Sustainability.
The Faculty of Science consists of six Departments: Biology, Pharmaceutical Sciences, Information and Computing Sciences, Physics and Astronomy, Chemistry and Mathematics. The Faculty is home to 3,500 students and nearly 2,000 staff members and is internationally renowned for the quality of its research. The Faculty's academic programmes reflect developments in today's society.
The Utrecht Institute for Pharmaceutical Sciences (UIPS) is the Research Institute of the Department of Pharmaceutical Sciences of Utrecht University. UIPS focuses on processes around discovery, development, and use of drugs and medical nutrition using molecular and technological principles from the Natural and Life Sciences. This research is ideally positioned in the Faculty of Science to work on basic scientific problems and to translate new findings into potential solutions to urgent societal medical needs, which are addressed in the Faculties of Medicine and Veterinary Medicine. Every year around 400 peer-reviewed articles are published and around 30 PhD candidates defend their thesis. UIPS is partner in several open source innovation networks.
As a Postdoc of pharmacoepidemiologic methods you will be employed in the Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences of the Faculty of Science, Utrecht University.
The Division of Pharmacoepidemiology & Clinical Pharmacology consists of a multidisciplinary team of young and internationally oriented researchers. The research programme is directed at several epidemiological, therapeutic, and policy aspects of chronic drug use with a focus on advanced affordable biomolecular and cellular therapies.
The Centre for Research Methods is embedded in the Division. Its mission is to develop, improve and evaluate innovative pharmacoepidemiologic methods. Main focus of the Centre is on methods to control for confounding in causal drug research, health technology assessment, precision medicine and increasing the validity and richness of data on drug exposure, disease outcomes, confounding (e.g. comorbidity, risk factors) and modifying (e.g. biomarkers) factors.
The main focus of the current position will be on development and evaluation of pharmacoepidemiologic methods to control for (un)measured confounding and multidatabase analysis with the overall aim to obtain reliable information on benefits and harms of medicines after marketing.